Statistics

Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)130

Select a period of time:

Number of views in the range

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)38

Views

Views
October 20253
November 20254
December 20257
January 202610
February 20261
March 202613
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Brazil6
United Kingdom5
Venezuela3
Argentina2
Guatemala1
Morocco1
Mexico1
Netherlands1
Paraguay1
 

Top cities views

Views
Ashburn6
San Jose4
Amsterdam1
Barra do Piraí1
Bauru1
Caxias do Sul1
Contagem1
East Longmeadow1
Guatemala City1
Jaboticabal1